aid: convergent-therapeutics
name: Convergent Therapeutics
description: 'Convergent Therapeutics, Inc. is a clinical-stage biotechnology company
  based in Cambridge, Massachusetts, developing next-generation targeted radiotherapies
  for cancer. Founded in 2020 by Philip Kantoff, the company builds alpha radioantibodies
  that pair a humanized monoclonal antibody against prostate-specific membrane antigen
  (PSMA) with the alpha emitter actinium-225, delivering short-range, high-energy alpha
  radiation to tumor cells. Its lead candidate, CONV01-alpha (rosopatamab tetraxetan),
  is in the Phase 2 CONVERGE-01 trial in metastatic castration-resistant prostate cancer,
  including patients previously treated with Lu-177 PSMA radioligand therapy, with a
  pivotal Phase 3 planned. Convergent announced a $90 million Series A financing in 2023.
  The company publishes a corporate website covering its pipeline, technology, scientific
  publications and press, but operates no public developer program, API, SDK, or
  machine-readable API contract.'
image: https://convergentrx.com/wp-content/uploads/2024/10/Convergent-Therapeutics-logo.svg
url: https://raw.githubusercontent.com/api-evangelist/convergent-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: enriched-no-api-surface
specificationVersion: '0.23'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Radiopharmaceuticals
- Clinical Trials
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/convergent-therapeutics-domain-security.yml
- type: Website
  url: https://convergentrx.com/
- type: About
  url: https://convergentrx.com/team/
- type: Team
  url: https://convergentrx.com/team/
- type: Products
  url: https://convergentrx.com/pipeline/
- type: Solutions
  url: https://convergentrx.com/technology/
- type: Research
  url: https://convergentrx.com/publications/
- type: News
  url: https://convergentrx.com/press/
- type: PressReleases
  url: https://convergentrx.com/press/
- type: Blog
  url: https://convergentrx.com/press/
- type: BlogFeeds
  url: https://convergentrx.com/feed/
- type: PrivacyPolicy
  url: https://convergentrx.com/privacy-policy/
- type: Contact
  url: mailto:info@convergentrx.com
- type: LinkedIn
  url: https://www.linkedin.com/company/convergent-therapeutics
- type: Marketplace
  url: https://forgeglobal.com/convergent-therapeutics_stock/
- type: LLMsTxt
  url: llms/convergent-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 3
  pass: local-v1